COVID-19 World Multivalent Vaccines Market Research Report (by Product Type, End-User/Application and Regions/Countries)

September 2020 | 106 pages | ID: C988BFD37CEBEN
HeyReport

Abstracts

SUMMARY


This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Multivalent Vaccines , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Multivalent Vaccines market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines

By End-User / Application

• Pediatrics
• Adults

By Company

• GlaxoSmithKline, plc (U.K.)
• Pfizer, Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Sanofi Pasteur SA (France)
• Astellas Pharma Inc. (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions, Inc. (U.S.)
• Johnson & Johnson (U.S.)
• MedImmune, LLC (U.S.)
• Serum Institute of India Pvt. Ltd. (India)
• Bavarian Nordic (Denmark)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Daiichi Sankyo (Japan)
• Protein Sciences Corporation (U.S.)
• Panacea Biotec (India)

Contents

PART 1 MARKET DEFINITION

1.1 Market Segment Overview
Figure Global Multivalent Vaccines Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Multivalent Vaccines Market and Growth by Type
1.3 by End-Use / Application
Table Global Multivalent Vaccines Market and Growth by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
Table Global Multivalent Vaccines Revenue (Million USD) by Vendors (2017-2019)
Table Global Multivalent Vaccines Revenue Share by Vendors (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Vendors (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
Table Global Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Global Multivalent Vaccines Market Share by Type (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Type (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
Table Global Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
Table Global Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Global Multivalent Vaccines Market Share by Regions (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Regions (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
  5.2.1 North America
Figure North America Market Growth 2015-2018
  5.2.2 Europe
Figure Europe Market Growth 2017-2019
  5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
  5.2.4 South America
Figure South America Market Growth 2017-2019
  5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019

6 NORTH AMERICA MARKET

6.1 by Type
Table North America Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table North America Multivalent Vaccines Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table North America Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table North America Multivalent Vaccines Market Share by Regions (2017-2019)

7 EUROPE MARKET

7.1 by Type
Table Europe Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Europe Multivalent Vaccines Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Europe Multivalent Vaccines Market Share by Regions (2017-2019)

8 ASIA-PACIFIC MARKET

8.1 by Type
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by Regions (2017-2019)

9 SOUTH AMERICA MARKET

9.1 by Type
Table South America Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table South America Multivalent Vaccines Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table South America Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Regions (2017-2019)

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Regions (2017-2019)

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
Figure Global Multivalent Vaccines Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Multivalent Vaccines Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market (Million USD) Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Share Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Multivalent Vaccines Market (Million USD) Forecast by Type (2020-2025)
Table Global Multivalent VaccinesMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Multivalent Vaccines Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Multivalent Vaccines Market Share Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS


12.BAYER GLAXOSMITHKLINE, PLC (U.K.)

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline, plc (U.K.)
12.2 Pfizer, Inc. (U.S.)
12.3 Merck & Co., Inc. (U.S.)
12.4 Sanofi Pasteur SA (France)
12.5 Astellas Pharma Inc. (Japan)
12.6 CSL Limited (Australia)
12.7 Emergent BioSolutions, Inc. (U.S.)
12.8 Johnson & Johnson (U.S.)
12.9 MedImmune, LLC (U.S.)
12.10 Serum Institute of India Pvt. Ltd. (India)
12.11 Bavarian Nordic (Denmark)
12.12 Mitsubishi Tanabe Pharma Corporation (Japan)
12.13 Daiichi Sankyo (Japan)
12.14 Protein Sciences Corporation (U.S.)
12.15 Panacea Biotec (India)

13 OVERVIEW OF INDUSTRY DEVELOPMENT (COVID-19)

13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Multivalent Vaccines Market and Growth by Type
Table Global Multivalent Vaccines Market and Growth by End-Use / Application
Table Global Multivalent Vaccines Revenue (Million USD) by Vendors (2017-2019)
Table Global Multivalent Vaccines Revenue Share by Vendors (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Vendors (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Global Multivalent Vaccines Market Share by Type (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Type (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Type (2017-2019)
Table Global Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by End-Use / Application (2017-2019)
Table Global Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Global Multivalent Vaccines Market Share by Regions (2017-2019)
Table Global Multivalent Vaccines Market Volume (Volume) by Regions (2017-2019)
Table Global Multivalent Vaccines Market Volume Share by Regions (2017-2019)
Table North America Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table North America Multivalent Vaccines Market Share by Type (2017-2019)
Table North America Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table North America Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table North America Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table North America Multivalent Vaccines Market Share by Regions (2017-2019)
Table Europe Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Europe Multivalent Vaccines Market Share by Type (2017-2019)
Table Europe Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table Europe Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Europe Multivalent Vaccines Market Share by Regions (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by Type (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Multivalent Vaccines Market Share by Regions (2017-2019)
Table South America Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table South America Multivalent Vaccines Market Share by Type (2017-2019)
Table South America Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table South America Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table South America Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Regions (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Type (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Multivalent Vaccines Market Share by Regions (2017-2019)
Table Global Multivalent Vaccines Market (Million USD) Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Share Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market Volume Share Forecast by Regions (2020-2025)
Table Global Multivalent Vaccines Market (Million USD) Forecast by Type (2020-2025)
Table Global Multivalent VaccinesMarket Share by Forecast Type (2020-2025)
Table Global Multivalent Vaccines Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Multivalent Vaccines Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline, plc (U.K.)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc. (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc. (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi Pasteur SA (France)
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma Inc. (Japan)
Table Sales Revenue, Volume, Price, Cost and Margin of CSL Limited (Australia)
Table Sales Revenue, Volume, Price, Cost and Margin of Emergent BioSolutions, Inc. (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of MedImmune, LLC (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of Serum Institute of India Pvt. Ltd. (India)
Table Sales Revenue, Volume, Price, Cost and Margin of Bavarian Nordic (Denmark)
Table Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma Corporation (Japan)
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo (Japan)
Table Sales Revenue, Volume, Price, Cost and Margin of Protein Sciences Corporation (U.S.)
Table Sales Revenue, Volume, Price, Cost and Margin of Panacea Biotec (India)

List Of Figures

LIST OF FIGURES

Figure Global Multivalent Vaccines Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Multivalent Vaccines Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Multivalent Vaccines Market Volume (Volume) and Growth Forecast (2020-2025)